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ABSTRACT 
Background: Pulmonary embolism (PE) is the most common preventable cause of hospital 
deaths, and almost all hospitalised patients have at least one risk factor for venous thrombo-
embolism (VTE). Despite the availability of highly effective thromboprophylaxis in prevent-
ing VTE, numerous studies worldwide have demonstrated its under-utilization. The aim of 
this study was to review and improve the utilization of thromboprophylaxis in the prevention 
of VTE in hospitalized patients at Oudtshoorn district hospital. 
Method: A quality improvement cycle (QIC). Retrospective analysis of files of adult patients 
admitted to the male and female wards at Oudtshoorn district hospital was performed prior to 
and after a 5 month intervention phase. The target standards for the QIC were: 1) Availability 
of a written hospital policy on VTE prevention; 2) Every adult admission should have a for-
mal VTE risk assessment documented; 3) Every adult admission who is at risk for VTE 
should receive thromboprophylaxis. 
Results: Thirty eight percent of adult patients admitted to Oudtshoorn hospital, excluding the 
maternity ward, were at risk of developing VTE. There was no written hospital policy on 
VTE prevention. This was developed and made available during the intervention. In the pre-
intervention group there were no patients who had a documented VTE risk assessment. The 
post intervention group showed a considerable increase with 45.2% having had a completed 
VTE risk assessment on admission (p<0.00001). In the pre-intervention group only 4.6 per-
cent of patients who were at risk of VTE received thromboprophylaxis.  There was a statisti-
cally significant difference in the number of patients at risk who received thromboprophylax-
is in the post-intervention group where 36% of these patients received thromboprophylaxis 
(p<0.00001). 
Conclusions: The study identified a major shortcoming in the prevention of VTE in those 
patients at risk who were admitted to Oudtshoorn district hospital. An intervention as part of 
a quality improvement cycle has been able to demonstrate a significant improvement in the 
detection of patients who are at risk of VTE and a subsequent improvement in appropriate 
thromboprophylaxis. A number of barriers to their implementation have been identified and 
need to be addressed. This QIC may in time be of value to assist other district hospitals in 
addressing the issue of VTE prevention. 
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Background 
Pulmonary embolism (PE) is the most common preventable cause of hospital deaths and is 
estimated to be the cause of approximately 10% of all deaths in hospitalized patients.
1,2
 In the
United Kingdom a recent parliamentary report noted up to 25 000 deaths per year from 
venous thromboembolism (VTE) associated with hospitalization.
3
Despite these alarming statistics, various international studies have demonstrated the under-
utilization of thromboprophylaxis for those patients who are at risk of developing VTE.
4
Interestingly, this is not limited to the developing world as studies in Canada found that less 
than 25% of at risk hospitalized patients received thromboprohylaxis.
4
 What is remarkable
about this deficit in patient care is that a multitude of randomized control trials over many 
years have demonstrated that thromboprophylaxis is highly effective in preventing VTE and 
PE.
1
 Almost all hospitalized patients have at least one risk factor for VTE and about 40%
have 3 or more risk factors.
1
 A multinational cross-sectional study of hospitalized patients
showed that on average 52% (range 35% to 73%) were at risk of VTE.
7
 Therefore, a
significant proportion of in-patients are at high risk of VTE and are not being protected 
against it.  
In the United States, hospital related PE has been ranked as the single most important 
intervention to improve patient safety in hospitals.
5
 The morbidity and mortality of VTE is
significant. A single deep vein thrombosis (DVT) is associated with a vastly increased risk of 
recurrent events and long term complications of VTE include post-thrombotic syndrome and 
pulmonary hypertension.
6
 These patients require long term anticoagulation with its associated
risks and costs. The annual costs involved with a single VTE event in the US have been 
estimated between $ 7594 and $ 16 644.
6
A number of international studies have attempted to bridge the gap between the established 
effectiveness of thromboprophylaxis and its clinical implementation. These studies have 
revolved around two main concepts. The first concept focused on which risk assessment 
models were accurate and user-friendly. These various models attempt to classify the degree 
of risk of VTE and are usually divided into medical and surgical models. The Southern 
African Society of Thrombosis and Haemostasis published the “Venous thromboembolism: 
Prophylactic and therapeutic practice guideline” in 2009, with a recent update in April 2013.2,
Stellenbosch University https://scholar.sun.ac.za
5 
13
 It contains a user-friendly table of VTE risk subcategories, which is combined for surgical 
and non-surgical patients.
2,13
 This guideline provides a practical tool for risk assessment as
well as recommendations on the means of thromboprophylaxis, but not measures to improve 
the rate of VTE prevention. 
Secondly, studies have looked to identify strategies to increase the use of thromboprophylaxis 
in at-risk patients.  They all support active initiatives as opposed to passive (e.g. distribution 
of guidelines) with the most successful strategies being multifaceted and multidisciplinary. 
The interventions include a formal hospital policy with organisational change, various doctor 
reminders and decision support systems, staff education programs, and regular audit 
processes. 
There is currently no data on the incidence of VTE in South Africa. The aim of this study was 
to review and improve the utilization of thromboprophylaxis in the prevention of VTE in 
hospitalized patients at Oudtshoorn district hospital, where this problem has been noted. The 
objectives were to assess the current quality of thromboprophylaxis; to plan and implement 
quality improvement measures; to determine if these were associated with a significant 
improvement in the quality of care; and to make recommendations to the Western Cape 
Department of Health on how to improve the quality of care for patients at risk for VTE at 
district hospitals. 
Methods 
Study design 
Quality improvement cycle (QIC).  The QIC involves a cycle consisting broadly of setting 
target standards; monitoring current performance and comparing it to the target; effecting 
change and assessing its effectiveness to improve the quality of care (see figure 1). 
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Figure 1: Steps of a quality improvement cycle. 
Setting 
Oudtshoorn provincial hospital is a district hospital with 123 beds in the Eden district of the 
Western Cape, South Africa,  serving a population of approximately 60 000 people. It has 
four wards (adult male, adult female, maternity, paediatric) an emergency centre, outpatient 
department and an anti-retroviral treatment clinic. The medical staff consists of 3 community 
service doctors and 7 medical officers. There is an average of 50 admissions per week to the 
general adult wards. 
In addition to general medical admissions, the hospital performs various elective level 1 
surgical procedures, including tonsillectomies, circumcisions, and caesarean sections. 
Emergency surgeries performed include laparotomies for ectopic pregnancies and 
appendicectomies. Visiting specialist disciplines include internal medicine, family medicine, 
obstetrics and gynaecology, surgery, orthopaedics, ENT and ophthalmology. 
Sampling and Data collection  
Data was collected at the beginning of 2012 from 250 patient files by the author. The sample 
consisted of consecutive admissions to the adult wards split evenly between the male and 
female wards. This was done retrospectively by checking the admission entries in the ward 
admission registers. This was intended to prevent bias which may have occurred if the 
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clinical team had been aware of an audit taking place. The sample size was determined with 
the help of the Department of Statistics at Stellenbosch University.  Patient files were 
examined for the following variables: 
1) Was a formal risk assessment done during admission?
2) What sub-category of VTE risk (low, moderate, high) was the patient?
3) Was thromboprophylaxis provided if at risk?
From this data the actual performance of the hospital in relation to each of the pre-determined 
criteria was analysed, and captured in an Excel spreadsheet.  
Setting target standards 
Almost all research and guidelines on this topic originate from a developed world setting. 
The American College of Chest Physicians (ACCP) recommends that every hospital develop 
a written policy and an active strategy to prevent VTE.
1
  In the United States the National
Quality Forum and the Joint Commission both recommend that a formal risk assessment 
evaluation for VTE should be done on each patient on admission and regularly thereafter. 
Locally, the guidelines of the Southern African Society of Thrombosis and Haemostasis 
provides “clinical” standards focused on the desired outcomes of care, but not structural or 
process standards to improve the rate of appropriate thromboprophylaxis prescription.
2 
The
target standards used for this QIC were as follows: 
Structural: A written hospital policy on VTE preventions. This included the various strategies 
needed to provide quality thromboprophylaxis. 
Process: Every adult admission should have had a formal VTE risk assessment documented. 
Outcome: Every adult admission who was at risk for VTE should have received 
thromboprophylaxis. This may have taken the form of pharmacological or non-
pharmacological means.  
Comparing actual performance to target standards. 
The analysed data was compared with the target standards set out above. 
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Planning changes to improve quality. 
The interventions included a formal hospital policy with organisational changes, various 
doctor reminders and decision support systems, staff education programs, and regular audit 
processes. Various studies including a systematic review of interventions to improve 
prophylaxis for VTE have found that a number of active strategies implemented together are 
most likely to be successful in achieving optimal outcomes.
17
In a discussion that the author had with the hospital manager, medical manager, most of the 
hospital doctors, male and female ward nursing managers and senior pharmacist a number of 
interventions that would be implemented to improve the quality of thromboprophylaxis were 
agreed to be implemented(see figure 2).  
Figure 2: Intervention strategies used in the study 
Implementing change.  
This took place over a 5 month period from July to November 2012. 
Provider education: 
This included regular interaction with doctors and nursing staff on the importance of VTE 
prevention, the use of the risk assessment tool provided and the correct utilization of 
thromboprophylaxis options.  
An initial interactive teaching session was held which provided the results of the current 
performance and compared it to the target standards. During this session the risk assessment 
tool was introduced and its use explained with the use of various patient scenarios. Follow up 
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sessions were held with the doctors and nursing staff. These were intended to address 
concerns and uncertainties as well as to reinforce the clinical importance of the intervention. 
Provider reminder and decision support: 
A stamp was adapted from a VTE intervention used by the Salisbury NHS Foundation Trust 
in Salisbury, United Kingdom to include the risk subcategories of the Southern African 
Society of Thrombosis and Haemostasis VTE guidelines (see figure 3).
19 
It was placed on the
back of the prescription chart where doctors’ orders were written and served to remind 
doctors to assess patients’ risk on admission and to prescribe appropriate thromboprophylaxis 
if indicated. If heparin was contraindicated in patients at risk of VTE the reason needed to be 
specified on the stamp. The nursing staff was requested to check whether the stamp had been 
completed. If not, they were to notify the ward doctor.  
Figure 3: Stamp placed on treatment charts.  Adapted from the Salisbury NHS Foundation 
Trust VTE prevention strategy.
19
The risk assessment tool of the Southern African Society of Thrombosis and Haemostasis 
was chosen for the intervention due its ease of use and because it takes into account the local 
context with its high burden of human immunodeficiency virus (HIV) and tuberculosis (TB) 
which most international tools fail to include. The fact that HIV infection causes a 
hypercoaguable state is well documented, with the prevalence of VTE in the HIV infected 
population estimated to be as high as 18%. 
14, 15 
The tool was made available in the form of posters which were placed at each desk in the 
emergency centre and outpatients department as well as at the work stations of the adult 
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wards. They were placed in a manner to be easily visible during the admission process of 
patients. Laminated A4 cards were also placed at each of these sites and on the ward round 
trolleys of the male and female wards. 
Audit and feedback 
An audit was performed at 5 months post intervention (see data collection post-intervention 
below). It is recommended that this is repeated six-monthly by the medical manager and/or 
family physician with feedback to the clinical staff. 
Hospital policy on VTE prevention 
Together with the hospital manager, a policy was drawn up entitled: Oudtshoorn Hospital 
Policy on Venous Thrombo-Embolism (VTE) prevention. Its stated purpose was to establish 
an effective, sustainable approach to the prevention of VTE in adult patients admitted to 
Oudtshoorn Hospital.  
Data collection post-intervention 
A repeat retrospective analysis was conducted 5 months after the initiation of the intervention 
to determine whether the prevalence of correct thromboprophylaxis administration had 
changed.  An additional sample of 199 patient files was assessed retrospectively for the same 
variables, and included consecutive admissions to the male and female wards. 
Results 
The study participants in the pre and post-intervention groups consisted of adults admitted to 
the male and female wards. There were equal numbers of male and female patients in the pre-
intervention group. The post intervention group showed a 59% male to 41% female split.   
In the pre-intervention group there were no patients who had a documented VTE risk 
assessment. The post intervention group showed a considerable increase with 90 patients 
(45.2%) having had a completed VTE risk assessment stamp on the admission chart 
(P<0.00001). See figure 4. 
Figure 4: VTE risk assessments documented in patient notes on admission 
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Patients are deemed at risk of VTE if they fall into the moderate or high risk categories. 
There was no statistically significant difference in the number of patients at risk of VTE 
between the pre and post-intervention groups (p=0.07861). The pre-intervention group 
included 86 patients at risk (34.4%) and the post-intervention group included 84 patients 
(42.7%). The reasons for this small difference between the two groups were not clear from 
the data. See Figure 5. 
Figure 5: Risk categories of patients admitted 
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In the pre-intervention group, 86 patients were at risk of VTE. Of these only 4 patients 
received thromboprophylaxis (4.6%).  There was a statistically significant difference in the 
number of patients at risk who received thromboprophylaxis in the post-intervention group 
where 31 of the 85 patients (36%) at risk received thromboprophylaxis (p<0.00001). See 
Figure 6. 
Figure 6: Patients at risk of VTE who received thromboprophylaxis 
Discussion 
A large proportion of adult patients admitted to Oudtshoorn hospital were at significant risk 
of developing VTE. The average percentage in the pre- and post-intervention groups showed 
that 38.5% of all adult admissions were at moderate to high risk. This equates to slightly 
more than one in three admissions. It is not known how many of these patients actually 
developed either a DVT or PE. It is very likely that other district hospitals in the Western 
Cape who have comparable patient demographics and burden of disease would have similar 
percentages of patients at risk of VTE.  
International data suggests a higher VTE risk than we found with this study. This may be due 
to an under-estimation of the actual risk, as the calculation of risk was done retrospectively 
by reviewing patient files. Various risk factors could not be easily elicited such as the body 
mass index (BMI) of the patient and a past history of DVT which is not routinely asked and 
recorded in patient notes. It may also be due to the use of different risk assessment guidelines. 
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The ENDORSE multinational cross-sectional study of 358 hospitals in 32 countries found 
that on average 52% of adult patients were at risk of VTE (range 35-73%). This was based on 
the American College of Chest Physicians consensus guidelines.
7
 Utilizing these same
guidelines a cross sectional survey of 12 hospitals in Senegal found that 57 % of patients 
were at risk of VTE. Both of these studies included medical admissions above the age of 40 
and surgical admissions above 18 years of age.
8
Prior to this intervention there was no strategy to prevent VTE at Oudtshoorn Hospital. The 
use of thromboprophylaxis was haphazard and was often only the continuation of treatment 
in a patient referred back from specialist care at the local referral hospital. There were no 
structured means of identifying patients who were at risk. This is clear from the fact that no 
patients had a formal VTE risk assessment, and that only 4.6% of patients at risk of VTE 
received thromboprophylaxis.  
The under-utilization of thromboprophylaxis is a world-wide problem that is not limited to 
the developing world. Alarmingly, in the pre-intervention group of this study the rate of 
appropriate thromboprophylaxis use (4.6% of patients at risk of VTE) was well below that 
cited internationally, where 58.5% of surgical and 39.5% of medical patients at risk received 
thromboprophylaxis.
7
 Data from another Sub-Saharan country showed that 33.8% of medical
and 37.5% of surgical patients at risk of VTE received thromboprophylaxis.
8
The intervention led to a statistically significant improvement in the number of risk 
assessments done (p<0.00001) and the percentage of patients at risk who received 
thromboprophylaxis (p<0.00001). This should be seen in light of the very poor performance 
before the intervention. It is however an indication that improvement is possible, and this 
could form the basis of an ongoing quality improvement program. The intervention was 
based on a number of strategies that have been employed in quality improvement programs 
internationally. Active quality improvement strategies in various hospitals in the UK based on 
similar interventions showed improvements in the rates of appropriate thromboprophylaxis 
from 59% to 70% (P<0.05) and from 25% to 77% (P<0.05)  respectively.
 9
There are multiple barriers to improving the quality of VTE prevention. They can 
conveniently be divided into three groups:
 6
1) Physician related barriers. These include underestimation of the risk of VTE and concern
over the risk of bleeding with thromboprophylaxis.
10
 Physicians are typically slow to
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change established practices and often see guidelines as threats to their autonomy as 
clinicians.
11  
Turnover of junior medical staff has also been cited as a reason for difficulty
in sustaining changes in prescribing behaviour.
12
  The author observed during data
collection for this study, that the more junior doctors (community service and first year 
medical officers) were more adherent in implementing the intervention than senior 
medical staff. This correlates with the resistance of physicians to change entrenched 
practices. In depth interviews of 40 doctors in two Australian hospitals specifically 
looking at improving VTE guideline uptake, demonstrated that senior clinicians were the 
key to changing current practices. This tied in with their findings that the practice of the 
clinical team was greatly influenced by senior team members.
16
Therefore it is vital is for the whole clinical team to “buy into” the process of changing 
established practices and to embrace the new intervention, a process that takes both time 
and persistence. 
Another barrier encountered in this study was that physicians tend to prioritize acute 
pathology and hence neglect preventative interventions such as risk stratification of 
patients, which are perceived as a waste of precious time in a busy casualty setting. 
2) Guideline-related barriers. This becomes a problem if there are multiple sets of
guidelines and especially if there is a variance in terms of recommendations between
them. We selected a single guideline and risk assessment tool and included it in the
hospital policy. Ease of use of the guideline is also an important barrier, with user friendly
and practical tools assisting implementation.
6
3) Environmental barriers. This includes a lack of hospital-specific protocols, lack of
decision support systems and resource limitations.
6
 This intervention has aimed to address
most of these barriers. A recent important advancement in the provision of VTE
prevention was that the low molecular weight heparin (LMWH), enoxaparin, has been
made available on general code in the Western Cape for prophylactic use. During the time
of the study unfractionated heparin (UFH) was still being used. As a result of this change
a once daily subcutaneous injection of LMWH is required, instead of a three times per
day injection for UFH.
One of the resource limitations experienced in the study was the lack of availability of 
anti-embolism stockings. It was a major challenge to ensure that the wards had stock of 
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the various sizes. These logistical issues will need to be addressed in future as the clinical 
team becomes more aware of the various options available to prevent VTE.  Anti-
embolism stockings were only prescribed once, which demonstrated that the doctors were 
not considering these as options for prophylaxis. With continued exposure to the 
intervention this will hopefully change. 
It was clear from reviewing the treatment chart and clinical notes that VTE prevention was 
not yet prioritized by medical staff. There was no emphasis on early removal of intravenous 
lines and urinary catheters and on early mobilization of patients. To be effective this will need 
a multi-disciplinary team approach that includes doctors, nursing staff and physiotherapists. 
This QIC has determined target standards that can be used for follow up audits to monitor 
performance. This is important in maintaining a sustainable intervention that has shown to be 
effective. There are a number of barriers that have been identified and which can be 
overcome. 
Limitations of this study 
For the majority of the study and for the full duration of the intervention the author was 
working at the local referral hospital. This made it difficult to provide a consistent drive to the 
intervention in terms of motivating and reminding the clinical team of the need to assess 
patients on admission for their VTE risk. The presence of such a person may have resulted in 
further improvements in outcomes. A dedicated person, most likely the medical manager or 
family physician, will be needed to carry this quality improvement program forward to ensure 
future sustainable improvement.  
There were a number of further logistical factors that limited the intervention. These included 
the presence of several locum doctors working at the hospital as well as visiting specialists. It 
was difficult for the author not being on site to involve these clinicians. As part of a continued 
intervention they need to be introduced to this aspect of clinical care at the hospital and 
familiarized with the local protocols. Unfortunately not all doctors who work at the hospital 
attended the educational meetings that formed part of the intervention.  
As mentioned above, the retrospective analysis of patient files was a methodological 
weakness of this study. Prospective analysis however, would have required patient consent 
with the potential for bias as patients being aware of the intervention would have placed 
pressure on clinicians to prescribe thromboprophylaxis, which may have skewed results.
18 
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Conclusion 
VTE is the most common preventable cause of hospital death. Thirty eight percent of adult 
patients admitted to Oudtshoorn hospital (excluding the maternity ward) was at risk of 
developing VTE. This study identified a major shortcoming in the prevention of VTE in these 
patients. An intervention as part of a quality improvement cycle was able to demonstrate a 
significant improvement in the detection of patients who are at risk of VTE and a subsequent 
improvement in the administration of appropriate thromboprophylaxis. Much still needs to be 
done to bring the quality of VTE prevention to that of the study target standards.  However, 
these targeted interventions have shown the potential to make a difference. A number of 
barriers to their implementation have been identified and will need to be addressed. This QIC 
may in time be of value in assisting other district hospitals to address the issue of VTE 
prevention. 
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